Strengthen the Group’s Medical Services Layout Further Consolidate its Leadership in Discretionary Medical Market EC Healthcare (the Company, which together…
Search Results: Frost (256)
Total Revenue Surged 81.1% Profit After Tax Surged 267.8% Further Consolidates the Healthcare Market EC Healthcare (the Company, which together…
EC Healthcare (the Company, which together with its subsidiaries is referred to as the Group, HKG: 2138), the largest non-hospital…
Empower and Consolidate Medical Asset Further Deepen the Group’s Medical Services Layout EC Healthcare (the Company, which together with its…
Industry elites examine key issues as global supply chain reshapes Jointly organised by the Government of the Hong Kong Special…
Key shareholders and senior management of China Risun Group Limited (China Risun, or the Group, HKG: 1907), a leading integrated…
Avance Clinical, the largest premium Australian CRO for international biotechs, is pleased to share the news that its client XWPharma…
EC Healthcare (the Company, which together with its subsidiaries is referred to as the Group, HKG: 2138), the largest non-hospital…
On July 20, 2021, Global New Material International Holdings Limited (Global New Material) (6616.HK), having developed pearlescent materials and synthetic…
Adlai Nortye, a global biopharmaceutical company focused on developing innovative oncology drugs, today announced that the first patient has been…
Daiwa Securities, in its recently published research report, has upgraded the rating for the parent company of Precision Tsugami (China)…
Profitability Increases Significantly Further Expands Business Coverage Through Mergers and Acquisitions and Operation Management China Risun Group Limited (China Risun,…
The parent company (the Group) of Asia’s leading technology logistics platform GOGOX submitted its listing application in Hong Kong. The…
Revenue Increases by Approximately 26.5% to RMB1,116.7 Million Further Expands Production Plant Network and Enlarges Share of Northern, Southern and…
EC Healthcare (the Company, which together with its subsidiaries is referred to as the Group, HKG:2138), the largest non-hospital medical…
EC Healthcare (the Company, which together with its subsidiaries is referred to as the Group, HKG: 2138), the largest non-hospital…
EC Healthcare (the Company, which together with its subsidiaries is referred to as the Group, HKG: 2138), the largest non-hospital…
The largest Australian full-service CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical…
EC Healthcare (the Company, which together with its subsidiaries is referred to as the Group, SEHK stock code: 2138), the…
New materials, with the new international situation, has become a key segment for overcoming market challenges, and is favoured by…